Core Viewpoint - The Hong Kong stock market is experiencing a surge in IPO activity, with multiple companies set to list in the coming days, indicating a robust market environment for new listings [1][3][18]. Group 1: Upcoming IPOs - On June 30, six companies announced their IPOs, with plans to list between June 30 and July 4, 2025 [1][3]. - The companies planning to list include Lens Technology, Fortior, Xunzhong Communication, Jizhi Jia, Dazhong Oral, and Shougang Longze, with Lens Technology and Fortior being A-share listed companies [1][3]. - Three companies, including Taide Pharmaceutical, Yunzhisheng, and IFBH, successfully listed on June 30, 2025, with Taide Pharmaceutical's share price set at 30.6 HKD [1][4]. Group 2: Financial Performance of Listed Companies - Yunzhisheng reported revenues of approximately 601 million RMB, 727 million RMB, and 939 million RMB for 2022, 2023, and 2024, respectively, with net losses of 375 million RMB, 376 million RMB, and 454 million RMB [4][6]. - Taide Pharmaceutical raised approximately 514 million HKD, with a net amount of about 429 million HKD after expenses, and secured two cornerstone investors contributing a total of 10 million USD [8]. - IFBH raised around 1.158 billion HKD, with a net amount of approximately 1.074 billion HKD, and is recognized as the second-largest coconut water beverage company globally [8]. Group 3: Market Trends and Future Outlook - The Hong Kong stock exchange has seen over 40 new listings in the first half of 2025, a significant increase compared to the same period in 2024, with total fundraising exceeding 100 billion HKD [17]. - The market is expected to remain active, with more companies preparing for IPOs, including those that have already submitted applications [17][18]. - The trend indicates a growing interest from A-share listed companies to enter the Hong Kong market, with over 70 companies submitting applications in June 2025 alone [17].

Core Viewpoint - The article provides an overview of upcoming IPOs in Hong Kong, highlighting key companies, their financials, and market positions. Group 1: CaoCao Inc. (曹操出行) - CaoCao Inc. plans to list on the Hong Kong Stock Exchange on June 25, 2025, with the stock code "2643" [3] - The company aims to issue 44.18 million shares globally, with 4.42 million shares for Hong Kong and 39.76 million shares for international investors [3] - CaoCao has secured 6 cornerstone investors, raising approximately HKD 952 million, including investments from Mercedes-Benz and other firms [3] - The expected IPO proceeds are HKD 1.853 billion, with a valuation of approximately HKD 22.823 billion [3] - Established in 2015, CaoCao is one of China's largest ride-hailing platforms, covering 136 cities and expanding to 85 new cities in 2024 [4] - The company's Gross Transaction Value (GTV) for 2023 and 2024 is projected at CNY 12.2 billion and CNY 17 billion, reflecting growth rates of 37.5% and 38.8% respectively [4] - In Q1 2024, CaoCao's GTV reached CNY 4.8 billion, a 54.9% increase year-on-year [4] - The company operates a fleet of over 34,000 customized vehicles, the largest among similar platforms in China [4] - CaoCao launched an autonomous driving platform in February 2024, with plans to introduce L4 Robotaxi models by the end of 2026 [5] - Revenue for 2022 to 2024 is reported at CNY 7.631 billion, CNY 10.668 billion, and CNY 14.657 billion, with a gross margin improvement from 5.8% in 2023 to 8.1% in 2024 [5][6] Group 2: SAINT BELLA Inc. (圣贝拉) - SAINT BELLA plans to list on the Hong Kong Stock Exchange on June 26, 2025, with the stock code "2508" [8] - The company intends to issue 95.42 million shares, with a maximum fundraising target of HKD 627 million and a valuation of HKD 3.918 billion [8] - SAINT BELLA has attracted 7 cornerstone investors, raising approximately HKD 323 million [8] - The company operates 96 high-end maternity centers under various brands, making it the largest postpartum care group in China and Asia [9] - Revenue from 2022 to 2024 is reported at CNY 472 million, CNY 560 million, and CNY 799 million, with a significant increase in contract values across its business lines [10] Group 3: Zhou Liu Fu (周六福) - Zhou Liu Fu plans to list on the Hong Kong Stock Exchange on June 26, 2025, with the stock code "6168" [12] - The company aims to issue 46.81 million shares, with expected proceeds of HKD 1.123 billion and a valuation of HKD 10.213 billion [13] - Zhou Liu Fu has secured 8 cornerstone investors, raising approximately HKD 573 million [13] - Established in 2004, Zhou Liu Fu operates 4,129 stores across 31 provinces, ranking among the top five jewelry brands in China [14] - Revenue from 2022 to 2024 is reported at CNY 3.102 billion, CNY 5.150 billion, and CNY 5.718 billion, with a compound annual growth rate of 35.8% [14][15] Group 4: Yunzhisheng (云知声) - Yunzhisheng plans to list on the Hong Kong Stock Exchange on June 30, 2025, with the stock code "9678" [17] - The company aims to issue 1.56 million shares, with a fundraising target of up to HKD 320 million and a valuation between HKD 11.7 billion and HKD 14.5 billion [18] - Yunzhisheng has attracted 3 cornerstone investors, raising approximately HKD 95.5 million [19] - Founded in 2012, Yunzhisheng is a leader in AGI technology and has developed a large language model, UniCore, and its successor, the Shan Hai model [20][21] - Revenue from 2022 to 2024 is reported at CNY 601 million, CNY 727 million, and CNY 939 million, with a compound annual growth rate of 25% [22] Group 5: IFBH Limited (if) - IFBH Limited plans to list on the Hong Kong Stock Exchange on June 30, 2025, with the stock code "6603" [25] - The company intends to issue 41.67 million shares, with a maximum fundraising target of HKD 1.158 billion and a valuation of approximately HKD 7.4 billion [26] - IF is the second-largest coconut water beverage company globally, with a market share of approximately 34% in China [27] - Revenue for 2023 and 2024 is reported at USD 87 million and USD 158 million, reflecting a growth rate of 80.3% [28]

Group 1: New Listings and Filings - Five companies submitted applications for listing on the Hong Kong Stock Exchange from April 7 to April 13, 2023 [2] - Hantian Technology (Xiamen) Co., Ltd. is a global leader in the silicon carbide (SiC) epitaxy industry, with a projected market share exceeding 30% in 2024 [2] - IFBH Limited, a rapidly growing beverage and food company based in Thailand, has a market share of approximately 34% in the coconut water market in mainland China for 2024 [3] - Jihong Co., Ltd. focuses on cross-border social e-commerce and packaging solutions, ranking second in the B2C export e-commerce sector in China with a market share of 1.3% [3] - Jiangxi Biological Products Research Institute is the largest provider of human tetanus antitoxin in China, with a market share of 65.8% in 2024 [4] Group 2: Financial Performance - Hantian Technology's projected revenues for 2022, 2023, and 2024 are approximately RMB 441 million, RMB 1.143 billion, and RMB 974 million, respectively [2] - IFBH Limited's revenues for 2023 and 2024 are expected to be approximately RMB 87.44 million and about USD 158 million, with net profits of RMB 16.75 million and USD 33.32 million [3] - Jihong Co., Ltd. anticipates revenues of approximately RMB 5.376 billion, RMB 6.695 billion, and RMB 5.529 billion for 2022, 2023, and 2024, respectively [3] - Jiangxi Biological's projected revenues for 2022, 2023, and 2024 are approximately RMB 142 million, RMB 198 million, and RMB 221 million, respectively [4] - Ming Kee Hospital Group, the largest private hospital group in East China, expects revenues of approximately RMB 2.336 billion, RMB 2.688 billion, and RMB 2.659 billion for 2022, 2023, and 2024 [5] Group 3: Upcoming IPOs - Zhengli New Energy plans to offer 121.5 million H-shares at an IPO price of HKD 8.27, with net proceeds of HKD 928 million [5] - Ying'en Biotechnology-B is set to offer 15.0716 million shares with a price range of HKD 94.6 to HKD 103.2, expected to start trading on April 15, 2025 [6]